Andere talen Voyageur Pharmaceuticals Ltd. Toronto S.E.

Aandelen

VM

CA92916K1057

Vertraagde tijd Toronto S.E. Andere beurzen			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
- ^CAD	-.--%		+7,14%	-.--%

26/04	Voyageur Pharmaceuticals Ltd. rapporteert resultaten voor het eerste kwartaal eindigend op 29 februari 2024	CI
26/03	Voyageur Pharmaceuticals Ltd. Rapporteert resultaten voor het volledige jaar eindigend op 30 november 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended February 29, 2024	26/04
Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors	03/04
Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options	26/03
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2023	26/03
Voyageur Pharmaceuticals Ltd. Announces A Significant Advancement in Its Partnership with Rain Cage Carbon Inc	13/03
Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development	13/03
Voyageur Pharmaceuticals Ltd. and Applied Pharmaceutical Innovation Sign Master Services Agreement	04/03
Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement	04/03
Voyageur Pharmaceuticals Ltd. Announces Closing of Private Placement	01/03
Voyageur Pharmaceuticals Ltd. announced that it has received CAD 0.4885 million in funding	01/03
Voyageur Pharmaceuticals Ltd. announced that it expects to receive CAD 0.8 million in funding	16/01
Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors	21/12
Voyageur Pharmaceuticals Ltd and Rain Cage Carbon Inc, Announce Breakthrough in Imaging Technology with Vanadium Fullerene Molecule	21/12
Voyageur Pharmaceuticals takes major step forward announcing international expansion	18/12
Voyageur Pharmaceuticals Ltd. Announces the Formalization of A Pivotal Sales and Distribution Alliance	14/12
Voyageur Pharmaceuticals Initiates International Expansion	14/12
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	30-10-23
Voyageur Pharmaceuticals "sees a gap in the market" for domestically-produced barium	28-09-23
Voyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast Media	14-09-23
Voyageur Pharmaceuticals Ltd. Announces Board Changes	01-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Voyageur Pharmaceuticals Ltd. Toronto S.E.

Aandelen

VM

CA92916K1057

Andere talen

Filters